Covered recipient · General Payments record
TIMOTHY R MCMULLEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$2,791.79
- Reported across 201 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $245.61 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $64.86 | 4 |
| Novo Nordisk AS | $33.44 | 2 |
| Acerta Pharma LLC | $28.25 | 2 |
| Xeris Pharmaceuticals, Inc. | $24.97 | 1 |
| DEXCOM, INC. | $24.57 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.12 | 1 |
| Lilly USA, LLC | $18.26 | 1 |
| PFIZER INC. | $15.49 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.65 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (14)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.96 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105009245 | CMS |
| ABBVIE INC. | $13.27 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105009247 | CMS |
| ABBVIE INC. | $15.29 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105009249 | CMS |
| ABBVIE INC. | $19.34 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105009251 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.47 | 02/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104768258 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.78 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105714596 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.65 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086223112 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $21.12 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118011525 | CMS |
| Dexcom, Inc. | $24.57 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153341183 | CMS |
| Lilly USA, LLC | $18.26 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135467749 | CMS |
| Novo Nordisk Inc | $17.45 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097125736 | CMS |
| Novo Nordisk Inc | $15.99 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096566032 | CMS |
| PFIZER INC. | $15.49 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131985177 | CMS |
| Xeris Pharmaceuticals, Inc. | $24.97 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144616043 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.